Pfizer Secures FDA Approval for Hemophilia Drug Hympavzi
Following the FDA approval, PFE's Hympavzi becomes the first hemophilia medicine approved in the United States to be ...
Ozempic, new intestinal therapy may eliminate need for insulin in Type 2 diabetics
Results from a new study suggest a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could ...
Hosted on MSN31m
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens.
PharmiWeb24m
Global Hemostasis Products Market Expected to Grow to USD 2.65 Billion by 2033 at a 5.3% of CAGR
Global Hemostasis Products MarketThe global hemostasis products market is poised for substantial growth, with an estimated valuation of USD 1.58 billion in 2023 and projected to exceed USD 2.65 ...